BPMX News and Press, BioPharmX Corporation. Common From 02/18/20

REHOVOT, Israel, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Pharma Two B Ltd., a privately held company developing innovative therapeutics based on previously approved drugs for Parkinson disease, announced today the appointment of David S. Tierney M.D. as Chief Executive Officer, effective imm...

ObsEva (NASDAQ: OBSV ) initiated with Buy rating and $19 (395% upside) price target at Kempen & Co. Shares up  8%  premarket. More news on: ObsEva SA, Selecta Biosciences, Inc., BioPharmX Corporation, Healthcare stocks news, Stocks on the move, , Read more ...

BioPharmX (NYSEMKT: BPMX ) and privately held Timber Pharmaceuticals have agreed to merge in an all-stock transaction. More news on: BioPharmX Corporation, Healthcare stocks news, Merger & acquisition news, Read more ...

SAN JOSE, Calif. and WOODCLIFF LAKE, N.J. , Jan. 28, 2020 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX)  ("BioPharmX") and Timber Pharmaceuticals LLC ("Timber"), a privately held biopharmaceutical company focused on the development and commercialization of treatment...

Are These Companies On Your Penny Stocks Watch List Right Now? It is a well-known fact that investors are always on the lookout for promising penny stocks. The simple reason behind that is the fact that these stocks can generate enormous returns. Over the years, many investors have made money ...

BioPharmX (NYSEMKT: BPMX ): Q3 Non-GAAP EPS of -$0.13; GAAP EPS of -$0.14 beats by $0.08 . More news on: BioPharmX Corporation, Earnings news and commentary, , Read more ...

SAN JOSE, Calif. , Dec. 10, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today reports financial results for the fiscal quarter ended October 31, 2019 . Corpor...

Would You Add These To Your Penny Stocks To Buy Or Sell List? Just like Santa has a naughty or nice list, traders have a penny stocks to buy or sell list. Or, at the very least a “ penny stocks to buy or avoid” list. No matter what you label it, the idea of creating a list of...

BioPharmX (NYSEMKT: BPMX ): Q2 GAAP EPS of -$0.22 beats by $0.12 . Cash and cash equivalents of $3.29M. Press Release More news on: BioPharmX Corporation, Earnings news and commentary, ,

SAN JOSE, Calif. , Sept. 9, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today reports financial results for the fiscal quarter ended July 31, 2019 . Recent H...